CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 1.945
-0.030 (-1.52%)
Aug 27, 2026, 3:52 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 1.18 billion as of August 27, 2026. Its market cap has increased by 4.85% in one year.
Market Cap
1.18B
Enterprise Value
1.12B
Revenue
55.62M
Ranking
n/a
PE Ratio
59.16
Stock Price
1.95
ChartMarket Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 1.18B, a decrease of -68.85%. That is a compound annual growth rate of -21.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.18B | -10.12% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
| Dec 10, 2021 | 3.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 1.84B |
| Mabpharm | 1.77B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.60B |
| SinoMab BioScience | 1.54B |
| Zhaoke Ophthalmology | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.28B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.26B |
| Cloudbreak Pharma | 1.01B |